HCAT vs. DCBO, WEAV, VTEX, TBLA, MOMO, AMPL, FSLY, VMEO, QUBT, and KIND
Should you be buying Health Catalyst stock or one of its competitors? The main competitors of Health Catalyst include Docebo (DCBO), Weave Communications (WEAV), VTEX (VTEX), Taboola.com (TBLA), Hello Group (MOMO), Amplitude (AMPL), Fastly (FSLY), Vimeo (VMEO), Quantum Computing (QUBT), and Nextdoor (KIND). These companies are all part of the "computer software" industry.
Health Catalyst vs.
Health Catalyst (NASDAQ:HCAT) and Docebo (NASDAQ:DCBO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, community ranking, dividends, media sentiment and earnings.
Health Catalyst received 103 more outperform votes than Docebo when rated by MarketBeat users. Likewise, 68.78% of users gave Health Catalyst an outperform vote while only 68.18% of users gave Docebo an outperform vote.
Health Catalyst has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Comparatively, Docebo has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500.
Docebo has a net margin of 8.63% compared to Health Catalyst's net margin of -26.20%. Docebo's return on equity of 50.22% beat Health Catalyst's return on equity.
Health Catalyst currently has a consensus target price of $10.20, suggesting a potential upside of 95.03%. Docebo has a consensus target price of $57.36, suggesting a potential upside of 46.00%. Given Health Catalyst's higher probable upside, equities research analysts plainly believe Health Catalyst is more favorable than Docebo.
Docebo has lower revenue, but higher earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Docebo, indicating that it is currently the more affordable of the two stocks.
85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 53.2% of Docebo shares are owned by institutional investors. 2.5% of Health Catalyst shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
In the previous week, Docebo had 1 more articles in the media than Health Catalyst. MarketBeat recorded 6 mentions for Docebo and 5 mentions for Health Catalyst. Docebo's average media sentiment score of 1.32 beat Health Catalyst's score of 0.75 indicating that Docebo is being referred to more favorably in the news media.
Summary
Docebo beats Health Catalyst on 13 of the 19 factors compared between the two stocks.
Get Health Catalyst News Delivered to You Automatically
Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Health Catalyst Competitors List
Related Companies and Tools
This page (NASDAQ:HCAT) was last updated on 2/22/2025 by MarketBeat.com Staff
